New discovery in T-Cell Research could lead to improved treatment of Solid Tumours

A local study led by the Agency for Science, Technology and Research (A*STAR) discovered that by inhibiting the function...

October 25, 2023 | Wednesday | Analysis
LianBio inks $350 M deal with Bristol Myers Squibb to provide cardiac drug in China & other Asian markets

LianBio, a biotechnology startup dedicated to bringing innovative medicines to patients in China and other major Asian m...

October 25, 2023 | Wednesday | News
US FDA funds Australian research for better, affordable asthma inhalers

Australian researchers have been awarded $AU1 million ($687,000) from the US Food and Drug Administration (FDA) to devel...

October 23, 2023 | Monday | News
Singapore develops innovative magnetic gel to heal diabetic wounds faster

Diabetic patients, whose natural wound-healing capabilities are compromised, often develop chronic wounds that are slow ...

October 20, 2023 | Friday | News
PolyU and Rohto join forces to establish Centre of Research Excellence for eye care in Hong Kong

The Hong Kong Polytechnic University (PolyU) has partnered with Rohto, an eye care brand under Mentholatum, to establish...

October 17, 2023 | Tuesday | News
Singapore explores genetic glycoengineering to advance vaccines & therapeutics technology

A novel glycoengineering platform, created by the researchers at Yong Loo Lin School of Medicine, National University of...

October 17, 2023 | Tuesday | News
Australian government injects $15 M for new cancer fighting research centre

The Australian government is funding ground breaking research that will revolutionise drug development for prostate and ...

October 13, 2023 | Friday | News
Saudi Arabia’s Vaccine Industrial Company advances novel infectious disease solutions

UK-based Emergex Vaccines Holding has signed a Memorandum of Understanding with the Saudi Arabia-based startup Vaccine I...

October 10, 2023 | Tuesday | News
Agilent and Sarawak Infectious Disease Centre boost NTDs research in East Malaysia

Agilent Technologies Inc. has announced the signing of a Memorandum of Understanding (MoU) with the Sarawak In...

October 6, 2023 | Friday | News
Australia's CSL inks global research agreements to fast-track therapeutics innovation

Australian behemoth CSL’s Research Acceleration Initiative (RAI) continues to expand its reach with seven medical ...

October 6, 2023 | Friday | News
Junshi Biosciences receives IND approval in China’s for DotBio's first multi-target oncology candidate

Singapore headquarterd biopharmaceutical company DotBio, excelling in antibody therapeutic modalities announced tha...

September 7, 2023 | Thursday | News
Singapore sets up new research centre to address lung diseases in Asian context

To better tackle respiratory diseases in Singapore, Nanyang Technological University, Singapore (NTU Singapore) has set ...

September 21, 2023 | Thursday | News
Everest Medicines signs $125.5 M deal with Kezar Life Sciences for Greater China and other Asian markets

Everest Medicines has entered into a collaboration and license agreement with Kezar Life Sciences to develop and commerc...

September 21, 2023 | Thursday | News
Researchers in Australia “bioprint” living brain cell networks in lab

Engineers at Australia's Monash University have successfully used “bioinks” containing living nerve cells (n...

September 20, 2023 | Wednesday | News
Agilent and ACTRIS partner to accelerate Cell and Gene Therapy in Singapore

Agilent Technologies Inc. has signed a Memorandum of Understanding (MoU) with the Advanced Cell Therapy and Research Ins...

September 10, 2023 | Sunday | News
Singapore National Eye Centre receives S$ 1 M to combat age-related macular degeneration

Tanoto Foundation has announced a donation of S$1 million to the Singapore National Eye Centre (SNEC) to support a three...

September 8, 2023 | Friday | News
MIT and Harvard announce new research alliance with Novo Nordisk for treatment of diabetes & CVDs

The Broad Institute of MIT (Massachusetts Institute of Technology)  and Harvard, in the US, hav...

September 6, 2023 | Wednesday | News
Bristol Myers Squibb inks $50 M deal to treat immune-mediated diseases in Asia

US-based startup Zenas BioPharma has entered into a license and collaboration agreement with Bristol Myers Squibb Compan...

September 6, 2023 | Wednesday | News